Holds 2 active US DMFs for gliclazide, filing since 2011. Its 2022 FDA inspection closed as VAI.
Holds 2 active US DMFs for gliclazide, filing since 2011. Its 2022 FDA inspection closed as VAI.
Holds one valid CEP for gliclazide, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Registered with SFDA (Saudi Arabia) for gliclazide.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Gliclazide manufacturer list to companies based in Italy. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free